Nautilus (Nasdaq: NAUT) is a company with a vision to revolutionize biomedicine by unlocking the complexity of the proteome.


Our mission is to positively impact the health and lives of people around the world.


How we get there

We were founded in 2016 on the belief that incremental advancements to existing technologies are inadequate; that a bold scientific leap is required to radically reinvent proteomics and create a new gold standard in the field. Nautilus exists to pursue deep, hard science and, ultimately, to positively impact the health of millions around the world.

Pursuing that goal is a leadership team with a unique combination of experiences in technology and life sciences, and a broader team made up of people from a wide spectrum of disciplines and expertise including protein chemists, chip designers, molecular biologists, data scientists, material scientists, biophysicists, optical engineers, microfluidics engineers, software engineers, and bioinformaticians.

Working to develop a product that will radically transform biomedicine



Sujal Patel

Founder & CEO

Sujal Patel is a successful technology entrepreneur and executive who founded and served as CEO of Isilon Systems, an enterprise data storage company. In 2006, Isilon completed one of the most successful initial public offerings of the year. Isilon was acquired by EMC in 2010 for $2.6 Billion, the largest acquisition in EMC’s history. Sujal served as the President of EMC’s Isilon Storage Division from the acquisition until 2012, driving significant revenue growth, market expansion and organizational scale. He graduated from the University of Maryland College Park in 1996 with a degree in Computer Science.

Parag Mallick, PhD

Founder & Chief Scientist

Dr. Parag Mallick is an Associate Professor at Stanford University, and an interdisciplinary scientist, who has developed multi-scale approaches to accelerate the discovery of diagnostic and prognostic protein biomarkers. Parag trained with pioneering researcher Ruedi Aebersold in clinical proteomics and systems biology at the Institute for Systems Biology. Parag holds a BS degree in Computer Science from Washington University in St. Louis, and a PhD in Chemistry & Biochemistry from UCLA. He has over 100 publications and holds patents in the fields of artificial intelligence, proteomics technology, biomarker development, and nanotechnology.

Anna Mowry

Chief Financial Officer

Anna is an experienced finance and business leader who joins Nautilus from Igneous where she served as VP of Finance and Operations with responsibility for finance, accounting, people, legal, and operations. Previously, Anna held a variety of roles at companies including Amazon Web Services and Isilon Systems, where she ultimately led the finance and sales operations organization. Anna has a BS in Biochemistry from Western Washington University and started her career at the Fred Hutchinson Cancer Research Institute. She earned her MBA from the University of Washington, leading her into a variety of finance and business roles of escalating responsibility.

Nick Nelson

Chief Business Officer

Nick Nelson has extensive leadership experience with top-tier diagnostics, therapeutics and life science companies. Before joining Nautilus, he was Chief Business Officer at Caris Life Sciences where he led all business development and strategic partnerships. Prior to Caris, he was Vice President of Commercial and Corporate Development at Trovagene (now Cardiff Oncology), and before that spent ten years at Illumina. While at Illumina he held leadership positions in the New and Emerging Markets business where he established partnerships and collaborations enabling high-growth genomics businesses. He received his Bachelor of Science degree in Cellular and Molecular Biology from San Diego State University.

Gwen Weld

Chief People Officer

Gwen has more than 25 years of senior leadership in human resources, organizational culture, and business strategy. She previously held the positions of Vice President of Global People and Infrastructure at Isilon Systems for more than six years and General Manager of Human Resources at Microsoft Corporation for nearly twenty years, leading Microsoft’s human resources agenda for its various groups and overseeing worldwide recruiting and alternative staffing. Ms. Weld studied business administration at Pace University.


Mary Godwin

SVP of Operations

Mary Godwin is a proven Operations and Supply Chain executive with deep experience across large corporations and smaller start ups. She brings to Nautilus deep experience developing processes and business relationships that improve both corporate metrics and financial performance. Before joining Nautilus, Mary held similar roles at Qumulo and Isilon Systems, where she built and scaled an operations function that supported over $1B in annual revenue. Prior experience included senior operational roles at Apple, Philips Electronics, and Lucent Technologies. She holds a Bachelor of Science degree in Plastics Engineering from the University of Massachusetts Lowell, and an MBA from Santa Clara University.

Subra Sankar, PhD

SVP of Product Development

Subra is a seasoned product and engineering leader who joins Nautilus from GenapSys where he served as SVP of Product Development, leading the company’s R&D efforts including Engineering, Assay, System Integration, Consumable Development, Informatics and a variety of chemistry and molecular biology groups. Subra has held many senior roles over the last 15 years, notably at Solexa/Illumina where, from 2006 to 2012, he led instrument and consumable development efforts for next gen sequencers and related products. Subra has a Ph.D. in Aerospace Engineering from Georgia Tech and an MBA from UC Berkeley.

Matthew Murphy, Esq.

General Counsel

Matt has spent over a quarter century advising companies on the cutting edge of life sciences technologies. He has held numerous General Counsel roles over this period, including most notably at Pacific Biosciences and 10X Genomics. He specializes in creating and defending industry defining patent portfolios, and in building and leading legal operations that help develop, finance and commercialize high growth companies. Matt received his Bachelor of Science in Microbiology and Fermentation Science from the University of California, Davis, and a Juris Doctorate from the University of San Francisco School of Law.

Chris Blessington

VP of Corporate Marketing & Communications

Chris is a proven marketing leader who joins Nautilus from Smartsheet where he served as VP of Marketing and Communications with responsibility for creating markets, building awareness, and driving revenue. Prior to that, he led marketing and communications at ExtraHop Networks and Isilon Systems through the company’s acquisition by EMC. At EMC/Isilon, he served as executive sponsor of the company’s Life Sciences and Genomics markets, leading product evangelism, market research, and sales preparedness. Chris holds a BS from Syracuse University.

Martin Huber Headshot

Martin Huber, PhD

VP of Biochemistry and Flow Cell Development

Martin brings to Nautilus over 20 years experience in biotechnology start-ups both in Europe and the US, most recently as founder, CTO and, ultimately, CEO of Quantapore, a company devoted to pioneering massively parallel, direct, single-molecule DNA and protein analytical tools. Prior to that, he held senior scientist positions at IonTorrent and Nanosphere. He holds an M.S. and Ph.D in Genetics and Biochemistry from the University of Vienna, Austria.

Sheri Wilcox, PhD

VP of Probe Development and Bioinformatics

Sheri spent 21 years at SomaLogic where she was instrumental in the development of the SomaScan Platform and SOMAmer reagents. As Associate Director of Aptamer Discovery she guided research of aptamers for biomarker discovery and directed the high-throughput generation of SOMAmer reagents, and as Senior Director of Analytical and Discovery Sciences, led SOMAmer discovery and characterization efforts, as well as several collaborations. Before joining SomaLogic, she was a postdoctoral fellow at Pharmacia, prior to its merger with Pfizer Inc. Dr. Wilcox received her B.S. in chemistry from Vanderbilt University, and her Ph.D. in macromolecular and cellular structure and chemistry from Scripps Research.


Board of Directors

Matt Posard

Board Chair, Founding Principal, Explore DNA

Former SVP & Head of Sales, Illumina

Karen Akinsanya

President of R&D, Therapeutics, Schrödinger

Michael Altman

Managing Director, Perceptive Advisors

Melissa Epperly

Former CFO, Zentalis Pharmaceuticals

Parag Mallick, PhD

Founder, Chief Scientist

Matt McIlwain

Managing Director, Madrona Venture Group

Farzad Nazem

Former EVP Engineering & CTO, Yahoo

Vijay Pande, PhD

General Partner, Andreessen Horowitz

Sujal Patel

Founder, Chief Executive Officer

Scientific Advisory Board

Ruedi Aebersold, PhD

Professor of Systems Biology
Institute of Molecular Systems Biology in ETH Zurich (IMSB) ​

  • Pioneer in the field ​of proteomics​
  • Co-founder of several companies and head of the biology/disease branch of ​the human proteome project

Lee Hartwell, PhD

President and Director Emeritus
Fred Hutchinson Cancer Research Center​

  • Discovered protein ​molecules that control ​the division of cells​
  • 2001 Co-recipient ​Nobel Prize in ​Physiology and Medicine

Joshua LaBaer, PhD

Executive Director
Biodesign Institute at Arizona State University​

  • Leading researcher in cancer and personalized medicine​
  • Inventor of the novel protein microarray technology, ​Nucleic Acid Programmable Protein Array (NAPPA), ​which has been used widely ​for biomedical research

Emma Lundberg, PD

Cell Atlas of the Human Protein Atlas

  • Professor in cell biology proteomics at KTH Royal Institute of Technology, Sweden
  • Pioneer in the field of spatial proteomics
  • Advocate of citizen science, advancing the use of gaming for science and health applications

Interested in joining our team?